InsiderClue
← All stocks

PLIANT THERAPEUTICS, INC.

PLRX Net selling
CIK 0001746473 #4543 in the set updated 21 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$25.42M
$8.23M on a plan · $11.35M straight out of an exercise
Sold at will
$5.83M
31 of 103 sales
Net
−$25.42M
−$5.83M against sales at will

By person

12 insiders · 116 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Coulie Bernard
President and CEO
—
$13.58M (51) scheduled
−$13.58M
1,364,235
2.20%
$1.75M
+50.4%
Lefebvre Eric
Chief Medical Officer
—
$5.13M (16)
−$5.13M
240,224
0.3879%
$307.49K
+32.2%
Cummings Keith Lamont
Chief Financial Officer
—
$2.97M (12) scheduled
−$2.97M
297,214
0.4800%
$380.43K
+3,839%
Hull Hans
Chief Business Officer
—
$1.89M (9) scheduled
−$1.89M
265,693
0.4291%
$340.09K
+111.6%
Ouimette Mike
General Counsel & Corp. Sec'y
—
$1.79M (12) scheduled
−$1.79M
105,544
0.1704%
$135.10K
—
Cheung Lily
Chief Human Resource Officer
—
$51.54K (2) scheduled
−$51.54K
44,847
0.0724%
$57.40K
+956.2%
Kuo Minnie
Chief Operating Officer
—
$8.85K (1) scheduled
−$8.85K
37,806
0.0611%
$48.39K
−15.5%
Third Rock Ventures III, L.P. entity
10% owner
—
—
—
3,972,027
6.41%
$5.08M
+1,320%
Redmile Group, LLC entity
10% owner
—
—
—
1,910,657
3.09%
$2.45M
—
Huh Hoyoung
Director
—
—
—
239,619
0.3870%
$306.71K
+140.2%
Howes Barbara
Chief Human Resource Officer
—
—
—
24,799
0.0400%
$31.74K
+18.2%
Exter Neil
Director
—
—
—
0
0.0000%
$0.00
—

Individual transactions

31
Insider
Date
Role
Action
Shares
Price
Amount
Lefebvre Eric
23 Jan 2023
Chief Medical Officer
Sell
67,500
$34.48
$2.33M
Ouimette Mike
22 Dec 2022
General Counsel & Corp. Sec'y
Sell
2,928
$19.38
$56.73K
Hull Hans
20 Dec 2022
Chief Business Officer
Sell
8,748
$19.10
$167.11K
Ouimette Mike
20 Dec 2022
General Counsel & Corp. Sec'y
Sell
4,719
$19.10
$90.14K
Lefebvre Eric
20 Dec 2022
Chief Medical Officer
Sell
10,887
$19.10
$207.97K
Coulie Bernard
20 Dec 2022
President and CEO
Sell
34,212
$19.10
$653.53K
Cummings Keith Lamont
20 Dec 2022
Chief Financial Officer
Sell
9,643
$19.10
$184.20K
Lefebvre Eric
25 Oct 2022
Chief Medical Officer
Sell
5,000
$25.05
$125.24K
Lefebvre Eric
11 Jul 2022
Chief Medical Officer
Sell
3,000
$20.00
$60.00K
Lefebvre Eric
18 Jun 2021
Chief Medical Officer
Sell
22
$30.23
$665.06
Lefebvre Eric
18 Jun 2021
Chief Medical Officer
Sell
3,728
$29.43
$109.72K
Lefebvre Eric
18 Jun 2021
Chief Medical Officer
Sell
8,750
$28.62
$250.44K
Coulie Bernard
14 Jun 2021
President and CEO
Sell indirect
243
$33.69
$8.19K
Coulie Bernard
14 Jun 2021
President and CEO
Sell indirect
3,757
$32.98
$123.92K
Coulie Bernard
14 May 2021
President and CEO
Sell indirect
503
$29.28
$14.73K
Coulie Bernard
14 May 2021
President and CEO
Sell indirect
2,997
$28.53
$85.50K
Coulie Bernard
14 Apr 2021
President and CEO
Sell indirect
3,500
$30.33
$106.16K
Lefebvre Eric
18 Mar 2021
Chief Medical Officer
Sell
1,135
$39.78
$45.15K
Lefebvre Eric
18 Mar 2021
Chief Medical Officer
Sell
11,365
$39.38
$447.53K
Coulie Bernard
15 Mar 2021
President and CEO
Sell indirect
178
$39.69
$7.06K
Coulie Bernard
15 Mar 2021
President and CEO
Sell indirect
2,000
$38.75
$77.50K
Coulie Bernard
15 Mar 2021
President and CEO
Sell indirect
1,322
$38.03
$50.27K
Coulie Bernard
16 Feb 2021
President and CEO
Sell indirect
200
$34.07
$6.81K
Coulie Bernard
16 Feb 2021
President and CEO
Sell indirect
2,100
$32.87
$69.02K
Coulie Bernard
16 Feb 2021
President and CEO
Sell indirect
1,200
$32.10
$38.52K
Coulie Bernard
14 Jan 2021
President and CEO
Sell indirect
630
$27.21
$17.15K
Coulie Bernard
14 Jan 2021
President and CEO
Sell indirect
2,870
$26.20
$75.18K
Lefebvre Eric
18 Dec 2020
Chief Medical Officer
Sell
5,712
$26.98
$154.11K
Lefebvre Eric
18 Dec 2020
Chief Medical Officer
Sell
6,788
$26.17
$177.64K
Coulie Bernard
14 Dec 2020
President and CEO
Sell indirect
337
$27.86
$9.39K
Coulie Bernard
14 Dec 2020
President and CEO
Sell indirect
3,163
$27.32
$86.40K
Show all 116 transactions →

What was left out

Form 4 filings counted 188
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 34
Sales straight out of an exercise 38
Sales at will 31
Transactions with no price 0
Shares from compensation/vesting 16,043,681
Sales filed before the plan box existed 31
History held since 9 Jun 2020